protein SSX2; synovial sarcoma, X breakpoint 2; tumor antigen HOM-MEL-40; cancer/testis antigen 5.2; CT5.2 (SSX2, SSX2A, SSX2B)
Jump to navigation
Jump to search
Function
- could act as a modulator of transcription
- interacts via its N-terminal region with RAB3IP & SSX2IP
Structure
Compartment
Alternative splicing
named isoforms=2
Expression
- expressed at high level in the testis
- expressed at low level in thyroid
- not detected in tonsil, colon, lung, spleen, prostate, kidney, striated & smooth muscles
- detected in rhabdomyosarcoma & fibrosarcoma cell lines
- not detected in mesenchymal & epithelial cell lines
Pathology
- chromosomal t(X;18)(p11.2;q11.2) involving SSX2 may be a cause of synovial sarcoma
- the translocation is specifically found in more than 80% of synovial sarcomas
- fusion products SSXT-SSX1 or SSXT-SSX2 are probably responsible for transforming activity
- heterogeneity in the position of the breakpoint can occur (low frequency)
More general terms
References
Database
- Entrez gene: http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene&cmd=Retrieve&dopt=Graphics&list_uids=6757
- Entrez gene: http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene&cmd=Retrieve&dopt=Graphics&list_uids=727837
- Kegg: http://www.genome.jp/dbget-bin/www_bget?hsa:6757
- Kegg: http://www.genome.jp/dbget-bin/www_bget?hsa:727837
- OMIM: https://mirror.omim.org/entry/300192
- UniProt: http://www.uniprot.org/uniprot/Q16385.html